Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Digital pathology in personalized cancer therapy.

Słodkowska J, García-Rojo M.

Stud Health Technol Inform. 2012;179:143-54. Review.

PMID:
22925795
2.

Digital pathology and image analysis in tissue biomarker research.

Hamilton PW, Bankhead P, Wang Y, Hutchinson R, Kieran D, McArt DG, James J, Salto-Tellez M.

Methods. 2014 Nov;70(1):59-73. doi: 10.1016/j.ymeth.2014.06.015. Review.

PMID:
25034370
3.

Digital microscopy imaging and new approaches in toxicologic pathology.

McCullough B, Ying X, Monticello T, Bonnefoi M.

Toxicol Pathol. 2004 Jul-Aug;32 Suppl 2:49-58. Review.

PMID:
15503664
4.

Digital image analysis in pathology: benefits and obligation.

Laurinavicius A, Laurinaviciene A, Dasevicius D, Elie N, Plancoulaine B, Bor C, Herlin P.

Anal Cell Pathol (Amst). 2012;35(2):75-8. doi: 10.3233/ACP-2011-0033. Review.

PMID:
21971321
5.

Digital imaging in anatomic pathology.

O'Brien MJ, Sotnikov AV.

Am J Clin Pathol. 1996 Oct;106(4 Suppl 1):S25-32. Review.

PMID:
8853053
6.

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69. Review.

PMID:
20014921
7.

Development of molecular biomarkers in individualized treatment of colorectal cancer.

De Mattos-Arruda L, Dienstmann R, Tabernero J.

Clin Colorectal Cancer. 2011 Dec;10(4):279-89. doi: 10.1016/j.clcc.2011.03.030. Review.

PMID:
21729679
8.

Twenty-first century pathology sign-out.

Tomlins S, Robinson D, Penny RJ, Hess JL.

Clin Lab Med. 2012 Dec;32(4):639-50. doi: 10.1016/j.cll.2012.07.002. Review.

PMID:
23078664
9.

Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.

Dietel M, Jöhrens K, Laffert M, Hummel M, Bläker H, Müller BM, Lehmann A, Denkert C, Heppner FL, Koch A, Sers C, Anagnostopoulos I.

Cancer Gene Ther. 2013 Apr;20(4):211-21. doi: 10.1038/cgt.2013.13. Review.

PMID:
23492822
10.

Revolution in lung cancer: new challenges for the surgical pathologist.

Cagle PT, Allen TC, Dacic S, Beasley MB, Borczuk AC, Chirieac LR, Laucirica R, Ro JY, Kerr KM.

Arch Pathol Lab Med. 2011 Jan;135(1):110-6. doi: 10.1043/2010-0567-RA.1. Review.

PMID:
21204716
11.

Personalized medicine for non-small-cell lung cancer.

Mok TS, Zhou Q, Leung L, Loong HH.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1601-11. doi: 10.1586/era.10.76. Review.

PMID:
20942631
12.

Personalized medicine in lung cancer: what we need to know.

Mok TS.

Nat Rev Clin Oncol. 2011 Aug 23;8(11):661-8. doi: 10.1038/nrclinonc.2011.126. Review.

PMID:
21862980
13.

Molecular pathology of lung cancer: key to personalized medicine.

Cheng L, Alexander RE, Maclennan GT, Cummings OW, Montironi R, Lopez-Beltran A, Cramer HM, Davidson DD, Zhang S.

Mod Pathol. 2012 Mar;25(3):347-69. doi: 10.1038/modpathol.2011.215. Review.

PMID:
22282308
14.

Personalized cancer medicine and the future of pathology.

Moch H, Blank PR, Dietel M, Elmberger G, Kerr KM, Palacios J, Penault-Llorca F, Rossi G, Szucs TD.

Virchows Arch. 2012 Jan;460(1):3-8. doi: 10.1007/s00428-011-1179-6. Review.

PMID:
22143935
15.

Targeted therapy of cancer: new roles for pathologists in colorectal cancer.

Hamilton SR.

Mod Pathol. 2008 May;21 Suppl 2:S23-30. doi: 10.1038/modpathol.2008.14. Review.

PMID:
18437170
16.

Gene expression significance in personalized medicine of non-small-cell lung cancer and gene expression analyzing platforms.

Zhang L, Yang H, Xu J.

Curr Drug Metab. 2011 Jun;12(5):455-9. Review.

PMID:
21453275
17.

Systems pathology--taking molecular pathology into a new dimension.

Faratian D, Clyde RG, Crawford JW, Harrison DJ.

Nat Rev Clin Oncol. 2009 Aug;6(8):455-64. doi: 10.1038/nrclinonc.2009.102. Review.

PMID:
19581910
18.

Digital imaging in pathology.

Park S, Pantanowitz L, Parwani AV.

Clin Lab Med. 2012 Dec;32(4):557-84. doi: 10.1016/j.cll.2012.07.006. Review.

PMID:
23078660
19.

[The change of pathology in the era of personalized medicine using the example of discordant KRAS mutational status in metastasized colorectal carcinoma].

Hekeler E, Zoller WG, Wiedorn KH, Bosse A.

Dtsch Med Wochenschr. 2012 Nov;137(45):2327-31. doi: 10.1055/s-0032-1327249. Review. German.

PMID:
23111797
20.

Predictive pathology in routine diagnostics of solid tumors.

Lassmann S, Werner M.

Histol Histopathol. 2012 Mar;27(3):289-96. Review.

PMID:
22237706
Items per page

Supplemental Content

Support Center